Clinical trialNCT02776878UnknownInterventional

A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GIST

SponsorPeking University Cancer Hospital & InstituteEnrollment57Gastrointestinal Stromal Tumor

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Shen Lin
Peking University Cancer Hospital & Institute
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China

Beijing Cancer Hospital
Beijing, Beijing Municipality, China
Shen Lin
Recruiting
Chinese Pla General Hospital
Beijing, Beijing Municipality, China
Wu Xin
Not, yet, recruiting
the First Affiliated Hospital,sun Yat-Sen University
Guangzhou, Guangdong, China
Zhang Xinhua
Not, yet, recruiting
No.81 Hospital of Chinese People'S Liberation Army
Nanjing, Jiangsu, China
Liu Xiufeng
Not, yet, recruiting
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
Zhou Ye
Not, yet, recruiting
Shanxi Cancer Hospital
Taiyuan, Shanxi, China
Liang Xiaobo
Not, yet, recruiting
West China Hospital , Sichuan University
Chengdu, Sichuan, China
Zhang Bo
Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 May 2016
Primary completion: 31 Oct 2017
Completion: 31 May 2018
Last update posted: 18 May 2016
Registered enrollment: 57
Registry id: NCT02776878

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.